TLX

NR2E1
Identifiers
AliasesNR2E1, TLL, TLX, XTLL, nuclear receptor subfamily 2 group E member 1
External IDsOMIM: 603849; MGI: 1100526; GeneCards: NR2E1
Available structures
PDBOrtholog search: PDBe RCSB
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001286102
NM_003269

NM_152229

RefSeq (protein)

NP_001273031
NP_003260

NP_689415

Location (UCSC)Chr 6: 108.17 – 108.19 MbChr 10: 42.44 – 42.46 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Nuclear receptor TLX, also known as nuclear receptor subfamily 2 group E member 1 (NR2E1), is a protein that in humans is encoded by the NR2E1 gene. TLX is a member of the nuclear receptor family of intracellular transcription factors and is a homologue of the Drosophila tailless gene.

TLX is part of the nuclear receptor subfamily 2 of retinoid X receptor-like proteins. However, unlike the retinoid X receptors, in typical physiologic circumstances it mostly binds to DNA by itself (as a monomer) instead of binding to another protein as a dimer. Using the type I-IV classification system, this means it's likely a type IV nuclear receptor.

Function

TLX regulates the expression of another nuclear receptor, retinoic acid receptor (RAR).[non-primary source needed]

TLX also is essential for normal brain-eye coordination and appears to play a role in control of aggressive behavior.

Adult neural stem cells are nuclear receptor TLX-positive and TLX expression in these cells is crucial in maintaining their undifferentiated state. Furthermore, TLX regulates adult neural stem cell proliferation. Removal of TLX from the adult mouse brain resulted in a reduction of stem cell proliferation and spatial learning.

Tlx-positive cells of the subventricular zone of adult mouse brain are self-renewing stem cells. Mutation of the Tlx gene in adult mouse brain leads to complete loss of neurogenesis in the subventricular zone. Tlx is also required for transition from radial glial cells to astrocyte-like neural stem cells.

Ligands

TLX was previously an orphan receptor, a receptor without a known endogenous ligand. However, it is now known that the fatty acid oleic acid as an endogenous agonist of TLX. Oleic acid is peripherally selective, necessitating the use of synthetic drugs to act on this receptor for potential medical applications.

Amdiglurax (NSI-189, ALTO-100) is a highly potent TLX agonist, with a reported EC50Tooltip half-maximal effective concentration of 36.1 pM (0.0361 nM) in an ALPHA assay.

TLX belongs to a small family of NRs that lack two helices in the ligand-binding domain, forming an enlarged binding pocket. Three compounds, termed ccrp1–3 (famprofazone, 1-(1,5-dimethylpyrazole-3-carbonyl)-4-(diphenylmethyl)piperazine, dydrogesterone), have been discovered in high-throughput screening that enhance TLX's ability of transcription repression with high potency.